keliximab
Sign in to saveKeliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
== References ==
Excerpted from Wikipedia’s “keliximab” article, available under the CC BY-SA 4.0 licence.